Cargando…

Comment on “Economic Burden and Medical Insurance Impact of the Different Dialysis for End-Stage Renal Diseases”

Detalles Bibliográficos
Autor principal:	Bayati, Mohsen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Tehran University of Medical Sciences 2019
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6500527/ https://www.ncbi.nlm.nih.gov/pubmed/31110995

Ejemplares similares

Economic Burden and Medical Insurance Impact of the Different Dialysis for End-stage Renal Diseases
por: GAO, Dan, et al.
Publicado: (2018)

Comment on: Estimating Economic Burden of Cancer Deaths Attributable to Smoking in Iran in 2012
por: Geravandi, Sara, et al.
Publicado: (2016)

The Impact of Health Insurance on Economic Burden for Hepatitis B Inpatients in China
por: ZHANG, Hua, et al.
Publicado: (2016)

Comment on: "Economic Burden of Thalassemia Major in Iran, 2015"
por: Rezaei, Satar, et al.
Publicado: (2016)

Why Is COVID-19 More Concentrated in Countries with High Economic Status?
por: Bayati, Mohsen
Publicado: (2021)

A few comments about the evaluation for small and diminutive colorectal polyps in end-stage renal disease patients
por: Lei, Tiantian, et al.
Publicado: (2022)

Transcatheter edge to edge mitral valve repair in patients with end-stage renal disease on dialysis: an analysis from the United States Renal Data System
por: Vindhyal, Mohinder R., et al.
Publicado: (2023)

Effect of peritoneal dialysis in end-stage renal disease on apixaban pharmacokinetics
por: Peyro-Saint-Paul, Laure, et al.
Publicado: (2023)

Metabolic syndrome in end stage renal disease
por: Mortazavi, Mojgan, et al.
Publicado: (2014)

End-stage Renal Disease in Griscelli Syndrome
por: Mahajan, Vidushi, et al.
Publicado: (2022)

The Burden of Cognitive Impairment in Patients With End-Stage Renal Disease and Impact on Dialysis Modality Choice
por: Jayanti, A., et al.
Publicado: (2016)

Comment on ‘End of the road for Essure®?’
por: Das, Sayantana, et al.
Publicado: (2018)

Combined Cardiac Impairments in End-Stage Renal Disease
por: Sobieszczańska, Małgorzata, et al.
Publicado: (2012)

Congenital nephrogenic diabetes insipidus with end-stage renal disease
por: Ryu, Hyun Ho, et al.
Publicado: (2015)

Refractory Hypercalcemia in a Patient with End Stage Renal Disease
por: Prabhahar, Arun, et al.
Publicado: (2022)

Infrequent Dialysis: A Different Strategy to Incremental Dialysis
por: Bolasco, Piergiorgio
Publicado: (2018)

Comment on a new treatment strategy for end-stage hepatic alveolar echinococcosis: IVC resection without reconstruction
por: Akbulut, Sami, et al.
Publicado: (2021)

Can health insurance help to improve the personal and economical health of India?
por: Mukhida, Sahjid S., et al.
Publicado: (2023)

Chronic inflammation in end-stage renal disease and dialysis
por: Cobo, Gabriela, et al.
Publicado: (2018)

Response of patients with sickle cell anaemia and end-stage renal disease to erythropoietin treatment
por: Zumrutdal, Aysegul
Publicado: (2010)

Several factors can alter the QTc interval in patients with end-stage renal disease
por: Gülgün, Mustafa
Publicado: (2016)

End-Stage renal disease and 30-day mortality for adults with and without COVID-19
por: Harrison, Stephanie L., et al.
Publicado: (2021)

Establishment of Reference Values for Non-HLA Antibodies in Patients With End-stage Renal Disease
por: Shin, Kyung-Hwa, et al.
Publicado: (2023)

Comment on the editorial “Health Economics in India: The case of diabetes mellitus”
por: Muralidhara, Koteshwara
Publicado: (2014)

Incidence and Economic Burden of Rhinoplastyin Tehran, Iran
por: Bidkhori, Mohammad, et al.
Publicado: (2022)

Comment on “The End of Phase 3 Clinical Trials in Biosimilars Development?”
por: Webster, Christopher J., et al.
Publicado: (2018)

The difference of T cell phenotypes in end stage renal disease patients under different dialysis modality
por: Xiaoyan, Jiao, et al.
Publicado: (2019)

Comment on: Prevention of Renal Damage by Treating Hyperuricemia
por: Nasri, Hamid, et al.
Publicado: (2015)

Comment on “Renal Protective Effect of Sirtuin 1”
por: Turkmen, Kultigin
Publicado: (2015)

Comment on “Factors affecting the clinical outcomes in pediatric post-cardiotomy patients requiring perioperative peritoneal dialysis”
Publicado: (2023)

Economic Burden of Anemia in an Insured Population
por: Nissenson, Allen R., et al.
Publicado: (2005)

To Compare Acute Peritoneal Dialysis with Sustained Low-efficiency Dialysis in Critically Ill Patients Requiring Renal Replacement Therapy
por: Datt, B., et al.
Publicado: (2017)

Diastolic dysfunction in end-stage renal disease patient: what the ticking clock has told us?
por: Chao, Chia-Ter
Publicado: (2011)

Diastolic dysfunction in end-stage renal disease patient: what the ticking clock has told us?
por: Duran, Mustafa, et al.
Publicado: (2011)

Unusual finding of cellular glomeruli infiltrated with lymphocytes in end stage renal disease due to obstructive nephropathy
por: Gaopande, V. L., et al.
Publicado: (2014)

Simultaneous pancreas-kidney transplantation for diabetic end-stage renal disease under a hypertension status
por: Xu, Shengqian, et al.
Publicado: (2015)

COVID-19 and the dental damage stage: a comment
por: Mungmunpuntipantip, Rujitika, et al.
Publicado: (2021)

Comment on “How may ChatGPT impact medical teaching?”
por: Kleebayoon, Amnuay, et al.
Publicado: (2023)

Comment on “Yield of Screening Colonoscopy in Renal Transplant Candidates”
por: Therrien, Amelie, et al.
Publicado: (2016)

Comment on: “Forecasting Pharmaceutical Prices for Economic Evaluations When There is No Market: A Review”
por: Holko, Przemysław
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_c9lej3alirqs1v4k5hie6luco0